Who is the CEO of ZyVersa Therapeutics, Inc.?

The CEO of ZyVersa Therapeutics, Inc. is Stephen C. Glover.

What industry does ZyVersa Therapeutics, Inc. belong to?

ZyVersa Therapeutics, Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is ZyVersa Therapeutics, Inc. headquartered?

ZyVersa Therapeutics, Inc. is headquartered at 2200 N. Commerce Parkway, Weston, FL, 33326, US.

What is the IPO date of ZyVersa Therapeutics, Inc.?

ZyVersa Therapeutics, Inc. went public on February 11, 2022.

How many employees does ZyVersa Therapeutics, Inc. have?

ZyVersa Therapeutics, Inc. has approximately 7 full-time employees.

ZyVersa Therapeutics, Inc.

ZVSA•NASDAQ

Healthcare

Biotechnology

$0.27

$0.03(12.50%)

ZyVersa Therapeutics, Inc. (ZVSA) Company Profile & Overview

Explore ZyVersa Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

ZyVersa Therapeutics, Inc. (ZVSA) Company Profile & Overview

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.

SectorHealthcare

IndustryBiotechnology

CEOStephen C. Glover

Contact Information

https://www.zyversa.com

754 231 1688

2200 N. Commerce Parkway, Weston, FL, 33326

Company Facts

7 Employees

IPO DateFeb 11, 2022

CountryUS

Actively Trading

Frequently Asked Questions

;